Dataset from A Randomized, Double-blind, Multicentre, Phase II Controlled Trial Assessing ZACTIMATM (Vandetanib) Against Placebo in Prolonging the Off-treatment Interval in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007713
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether treatment with Zactima for up to 18 months
will prolong the off-treatment interval in patients who are undergoing intermittent androgen
deprivation therapy.
创建时间：
2024-11-26
